---
layout: page
title: ç ”ç©¶æ¥­ç¸¾
permalink: /achievements.html
---

<a href="/en/achievements.html">[English Version]</a>

### ğŸ“š**å­¦è¡“è«–æ–‡**

1.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyama Otani, and Yoshihiro Yamanishi.  
Therapeutic target prediction for orphan diseases integrating genome-wide and transcriptome-wide association studies.  
Nat Commun., **16**, 3355.  
https://doi.org/10.1038/s41467-025-58464-4 (2025.4.18)  
[[Paper]](https://doi.org/10.1038/s41467-025-58464-4) [[PubMed]](https://pubmed.ncbi.nlm.nih.gov/40251160/) [[Google Scholar]](https://scholar.google.co.jp/citations?user=Oo9a2h8AAAAJ&hl)

3.	**â—‹Satoko Namba**, Chen Li, Noriko Otani, and Yoshihiro Yamanishi.  
   SSL-VQ: Vector-quantized variational autoencoders for semi-supervised prediction of therapeutic targets across diverse diseases.   Bioinformatics, **41**(2), btaf039,  
https://doi.org/10.1093/bioinformatics/btaf039 (2025.1.28)  
[[Paper]](https://doi.org/10.1093/bioinformatics/btaf039) [[PubMed]](https://pubmed.ncbi.nlm.nih.gov/39880378/) [[Google Scholar]](https://scholar.google.co.jp/citations?user=Oo9a2h8AAAAJ&hl)

5.	Midori Iida, ..., **â—‹Satoko Namba**, et al.  
   A network-based trans-omics approach for predicting synergistic drug combinations.  
  	Communications medicine, **4**, 154.  
https://doi.org/10.1038/s43856-024-00571-2. (2024/7/29)  
[[Paper]](https://doi.org/10.1038/s43856-024-00571-2) [[PubMed]](https://pubmed.ncbi.nlm.nih.gov/39075184/) [[Google Scholar]](https://scholar.google.co.jp/citations?user=Oo9a2h8AAAAJ&hl)

7.	Hanako Yoshimura, ..., **â—‹Satoko Namba**, et al.  
   Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.  
  	The Journal of allergy and clinical immunology, **153**(5), 1268-1281.  
https://doi.org/10.1016/j.jaci.2023.12.030. (4/4/2024)  
[[Paper]](https://doi.org/10.1016/j.jaci.2023.12.030) [[PubMed]](https://pubmed.ncbi.nlm.nih.gov/38551536/) [[Google Scholar]](https://scholar.google.co.jp/citations?user=Oo9a2h8AAAAJ&hl)

9.	**â—‹Satoko Namba**, Michio Iwata, & Yoshihiro Yamanishi.  
   From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.  
  	Bioinformatics (Oxford, England), **38**(Suppl 1), i68â€“i76.  
https://doi.org/10.1093/bioinformatics/btac240 (6/27/2022)  
[[Paper]](https://doi.org/10.1093/bioinformatics/btac240) [[PubMed]](https://pubmed.ncbi.nlm.nih.gov/35758779/) [[Google Scholar]](https://scholar.google.co.jp/citations?user=Oo9a2h8AAAAJ&hl)

---

### ğŸ“•**å­¦è¡“é›‘èªŒåˆã¯å•†æ¥­èªŒ**

1.	**â—‹é›£æ³¢é‡Œå­**.  
ã€ŒConference & Workshop AIãŒè§£ãæ˜ã‹ã™ç”Ÿå‘½ç§‘å­¦ã®æœªæ¥ï¼š1st Asia & Paciï¬c Bioinformatics Joint Conferenceã€ã€  
 å®Ÿé¨“åŒ»å­¦2025å¹´4æœˆå·Vol.43 No.6  
ã€ç‰¹é›†1ï¼šå¤šç´°èƒã®åˆæˆç”Ÿç‰©å­¦ã€€ç™ºç”Ÿãƒ»åˆ†åŒ–æ©Ÿæ§‹ã‚’çŸ¥ã£ã¦ã€å‰µã£ã¦ã€åˆ©ç”¨ã™ã‚‹ï¼ç‰¹é›†2ï¼šã¾ãšã¯Condaã§ã¯ã˜ã‚ã‚ˆã†ã€€ä»®æƒ³ç’°å¢ƒã§è©¦ã›ã‚‹ãƒã‚¤ã‚ªã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹ã€  
ï¼ˆæˆ¸ç”°è¡ï¼Œæ–°æµ·å…¸å¤«ï¼ç·¨ ç¾ŠåœŸç¤¾ã€2025å¹´3æœˆ19æ—¥ã€957-960ï¼‰.  
ISBN 978-4-7581-2590-1

2.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
   ã€Œéºä¼å­æ‘‚å‹•å¿œç­”ã‚ªãƒŸã‚¯ã‚¹ãƒ‡ãƒ¼ã‚¿ã‚’ç”¨ã„ãŸæ²»ç™‚æ¨™çš„äºˆæ¸¬â€•ç–¾æ‚£æ¨ªæ–­è§£æã«ã‚ˆã‚‹ã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ã€ã€  
  	å®Ÿé¨“åŒ»å­¦å¢—åˆŠVol.41 No.7ã€ãƒã‚¹ãƒˆGWASæ™‚ä»£ã®éºä¼çµ±è¨ˆå­¦ ã‚ªãƒŸã‚¯ã‚¹è§£æã¨æ©Ÿæ¢°å­¦ç¿’ã§ãƒ’ãƒˆç–¾æ‚£ã‚’ä¿¯ç°ã™ã‚‹ã€  
  	ï¼ˆå²¡ç”°éšè±¡ç·¨ ç¾ŠåœŸç¤¾ã€2023å¹´4æœˆ20æ—¥ã€181-187ï¼‰.  
ISBN 978-4-7581-0410-4

<!-- å®Ÿé¨“åŒ»å­¦2023 -->
<div style="display: flex; align-items: flex-start; gap: 20px; flex-wrap: wrap;">

  <!-- å·¦å´ï¼šåŸºæœ¬æƒ…å ± -->
  <div style="flex: 1; min-width: 250px;">
   1. <strong>â—‹é›£æ³¢é‡Œå­</strong>, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.<br>
     ã€Œéºä¼å­æ‘‚å‹•å¿œç­”ã‚ªãƒŸã‚¯ã‚¹ãƒ‡ãƒ¼ã‚¿ã‚’ç”¨ã„ãŸæ²»ç™‚æ¨™çš„äºˆæ¸¬â€•ç–¾æ‚£æ¨ªæ–­è§£æã«ã‚ˆã‚‹ã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ã€ã€<br>
  	  å®Ÿé¨“åŒ»å­¦å¢—åˆŠVol.41 No.7ã€ãƒã‚¹ãƒˆGWASæ™‚ä»£ã®éºä¼çµ±è¨ˆå­¦ ã‚ªãƒŸã‚¯ã‚¹è§£æã¨æ©Ÿæ¢°å­¦ç¿’ã§ãƒ’ãƒˆç–¾æ‚£ã‚’ä¿¯ç°ã™ã‚‹ã€<br>  
  	  ï¼ˆå²¡ç”°éšè±¡ç·¨ ç¾ŠåœŸç¤¾ã€2023å¹´4æœˆ20æ—¥ã€181-187ï¼‰.<br>
     ISBN 978-4-7581-0410-4
  </div>

  <!-- å³å´ï¼šé¡”å†™çœŸ -->
  <div style="flex-shrink: 0;">
    <img src="/assets/books/å®Ÿé¨“åŒ»å­¦2023.jpg" alt="å®Ÿé¨“åŒ»å­¦2023" style="width: 120px; border: 1px solid #ccc; height: auto;">
  </div>

</div>

---

### ğŸ†**å—è³**

1.	**â—‹é›£æ³¢é‡Œå­**ã€ææ™¨ã€å¤§è°·å‰‡å­ã€å±±è¥¿èŠ³è£•.  
ã€Œéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸåŠæ•™å¸«ã‚ã‚Šæ·±å±¤å­¦ç¿’ã«ã‚ˆã‚‹æ²»ç™‚æ¨™çš„åˆ†å­ã®äºˆæ¸¬ã¨å¸Œå°‘ç–¾æ‚£ã¸ã®å¿œç”¨,  
ã€ç¬¬130å› æ—¥æœ¬è§£å‰–å­¦ä¼šï¼ç¬¬102å› æ—¥æœ¬ç”Ÿç†å­¦ä¼šï¼ç¬¬98å› æ—¥æœ¬è–¬ç†å­¦ä¼šåˆåŒå¤§ä¼šã€,   
Young Investigator Award,  
åƒè‘‰, 2025å¹´3æœˆ18æ—¥ï¼ˆ2025.3.17~2025.3.19ï¼‰, ï¼ˆå—è³ç‡24/72=33.3%ï¼‰.  
[[è³çŠ¶]](https://satoko-namba.github.io/assets/docs/appw2025_award.jpg)

3.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Otani, and Yoshihiro Yamanishi.  
â€œTherapeutic target prediction for rare diseases integrating GWAS and TWAS dataâ€.  
ã€ç¬¬12å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€  
å„ªç§€ãƒã‚¹ã‚¿ãƒ¼è³ã€€å—è³,  
åƒè‘‰, 2023å¹´9æœˆ7æ—¥ ï¼ˆå—è³ç‡8/144=5.5%ï¼‰.  
[[è³çŠ¶]](https://satoko-namba.github.io/assets/docs/IIBMP2023_award.jpg)

5.	**â—‹é›£æ³¢é‡Œå­**, å°å·å‹å¸Œ, æ¨ªå±±æºå¤ªéƒ, æ¿±è°·å’Œ, ä¸‹æ²³èˆå­, æ­¦ç”°æ·³å¿—.  
â€œã‚¹ãƒšãƒ¼ã‚¹ã‚²ãƒãƒ  è§£æã¨ãã®æ´»ç”¨ã«ã¤ã„ã¦ã®è«¸è€ƒå¯Ÿâ€.  
ã€ç”Ÿå‘½æƒ…å ±ç§‘å­¦è‹¥æ‰‹ã®ä¼šã®ç¬¬14å›ç ”ç©¶ä¼šã€,  
Best NGS awards å—è³,  
ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2022å¹´9æœˆ10-11æ—¥.  
[[è³çŠ¶]](https://satoko-namba.github.io/assets/docs/BestNGS_award.jpg)

7.	**â—‹Satoko Namba**, Michio Iwata and Yoshihiro Yamanishi.  
â€œFrom drug repositioning to target repositioning: omics-based prediction of therapeutic targets for a variety of diseasesâ€.  
ã€CBIå­¦ä¼š2021å¹´å¤§ä¼šã€,  
å£é ­ç™ºè¡¨è³ å—è³ (Excellent Presentation Awards),  
ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2021å¹´10æœˆ27æ—¥ ï¼ˆå—è³ç‡4/34=11.7%ï¼‰.  
[[è³çŠ¶]](https://satoko-namba.github.io/assets/docs/CBI2021_award.jpg)

9.	**â—‹Satoko Namba**, Michio Iwata and Yoshihiro Yamanishi.  
ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ï¼šéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„äºˆæ¸¬ã€,  
ã€ç¬¬10å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€,  
å„ªç§€ãƒã‚¹ã‚¿ãƒ¼è³ å—è³,  
ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2021å¹´9æœˆ27æ—¥ (2021.9.27ã€œ2021.9.29) (å—è³ç‡9/86=10.4%).  
[[è³çŠ¶]](https://satoko-namba.github.io/assets/docs/IIBMP2021_award.jpg)

---

### ğŸ’°**ç«¶äº‰çš„ç ”ç©¶è³‡é‡‘**

1.	**é›£æ³¢é‡Œå­**, æ—¥æœ¬å­¦è¡“æŒ¯èˆˆä¼š ç‰¹åˆ¥ç ”ç©¶å“¡ (PD),  
ã€ŒGWASã¨TWASã®èåˆã«ã‚ˆã‚‹å¸Œå°‘ç–¾æ‚£ã®æ²»ç™‚æ¨™çš„åˆ†å­ã‚’äºˆæ¸¬ã™ã‚‹æƒ…å ±æŠ€è¡“ã®é–‹ç™ºã€,  
ç‰¹åˆ¥ç ”ç©¶å¥¨åŠ±é‡‘, ç§‘ç ”è²»ç•ªå· 25KJ0159, 2025.4~2028.3  
 (æ¡æŠç‡ 23.9%, â€»ç‰¹åˆ¥ç ”ç©¶å“¡-DCã«ç”³è«‹ã—ã€æ¡ç”¨æ™‚ã¾ã§ã«åšå£«ã®å­¦ä½ã‚’å–å¾—ã—ã¦ç‰¹åˆ¥ç ”ç©¶å“¡-PDã«è³‡æ ¼å¤‰æ›´ã—ãŸè€…ã‚’å«ã‚€).

2.	**â—‹Satoko Namba**,  
ISMB2022 Travel Fellowship, $1,000 ï¼ˆæ¡æŠç‡ 47/155ï¼‰  

3.	**é›£æ³¢é‡Œå­**,  
æ—¥æœ¬å­¦è¡“æŒ¯èˆˆä¼š ç‰¹åˆ¥ç ”ç©¶å“¡ (DC1),  
ã€Œæ²»ç™‚åŠ¹æœã‚’é«˜ã‚ã‚‹è–¬å‰¤çµ„ã¿åˆã‚ã›ã‚’äºˆæ¸¬ã™ã‚‹æƒ…å ±æŠ€è¡“ã®é–‹ç™ºã€,  
ç‰¹åˆ¥ç ”ç©¶å¥¨åŠ±é‡‘, ç§‘ç ”è²»ç•ªå· 22KJ2494, 2022.4~2025.3, ï¼ˆæ¡æŠç‡ 18.5%ï¼‰.


---

### ğŸ—£ï¸**æ‹›å¾…è¬›æ¼”**

1.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ï¼šéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„äºˆæ¸¬ã€,  
ã€ç¬¬5å›CBIè‹¥æ‰‹ã®ä¼šè¬›æ¼”ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2022å¹´6æœˆ3æ—¥.


---

### ğŸŒ**å›½éš›å­¦ä¼šã«ãŠã‘ã‚‹å£é ­ç™ºè¡¨ [æŸ»èª­æœ‰ã‚Šï¼½**

1.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyama Otani, and Yoshihiro Yamanishi.  
â€œTRESOR: a disease signature integrating GWAS and TWAS  for therapeutic target discovery in rare diseases.â€  
ã€The 33rd International Conference on Intelligent Systems for Molecular Biology (ISMB2025)ã€,  
Abstract Talk, è‹±å›½ ãƒªãƒãƒ—ãƒ¼ãƒ«, 2025.7.20â€“24.  

2.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œTarget repositioning to predict therapeutic target proteins using genetically perturbed transcriptome dataâ€.  
ã€The 31st International Conference on Intelligent Systems for Molecular Biology (ISMB2023)ã€,  
ã‚·ãƒ§ãƒ¼ãƒˆãƒˆãƒ¼ã‚¯ ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2023å¹´7æœˆ19æ—¥.

2.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œFrom drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signaturesâ€.  
ã€The 30th International Conference on Intelligent Systems for Molecular Biology (ISMB2022)ã€,  
Proceedings, ã‚¢ãƒ¡ãƒªã‚« ãƒãƒ‡ã‚£ã‚½ãƒ³, 2022å¹´7æœˆ12æ—¥ (2022.7.10~2022.7.14).  
[[ğŸ“ºYouTube]](https://www.youtube.com/watch?v=txB2THOWOAo)

---

### ğŸŒ**å›½éš›å­¦ä¼šã«ãŠã‘ã‚‹ãƒã‚¹ã‚¿ãƒ¼ç™ºè¡¨ [æŸ»èª­æœ‰ã‚Šï¼½**

1.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œA trans-disease approach for predicting therapeutic target proteins using large-scale omics dataâ€.  
ã€1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024)ã€,  
æ²–ç¸„ é‚£è¦‡, 2024å¹´10æœˆ24æ—¥ (2024.10.22~2024.10.25).  
[[ğŸ“ºYouTube]](https://www.youtube.com/watch?v=ubSPoumE6cM)

3.	Midori Iida, ..., **â—‹Satoko Namba**, et al.  
â€œA Computational Method for Predicting Synergistic Drug Combinations Using Network Propagation and Trans-Omics Analysisâ€.  
ã€1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024)ã€,  
æ²–ç¸„ é‚£è¦‡, 2024å¹´10æœˆ23æ—¥ (2024.10.22~2024.10.25).  

4.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œA trans-disease approach for omics-based prediction of therapeutic target proteinsâ€.  
ã€The 32nd International Conference on Intelligent Systems for Molecular Biology (ISMB2024)ã€,  
ã‚«ãƒŠãƒ€ ãƒ¢ãƒ³ãƒˆãƒªã‚ªãƒ¼ãƒ«, 2024å¹´7æœˆ15æ—¥ (2024.7.12~2024.7.16).  
[[ğŸ“ºYouTube]](https://www.youtube.com/watch?v=PgP2kvVNPE0)

5.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œTarget repositioning to predict therapeutic target proteins using genetically perturbed transcriptome dataâ€.  
ã€The 31st International Conference on Intelligent Systems for Molecular Biology (ISMB2023)ã€,  
ãƒ•ãƒ©ãƒ³ã‚¹ ãƒªãƒ¨ãƒ³, 2023å¹´7æœˆ24æ—¥ (2023.7.23~2023.7.27).  
[[ğŸ“ºYouTube]](https://www.youtube.com/watch?v=dCtTflzjZxY)

---

### ğŸ¯**å›½å†…å­¦ä¼šãƒ»ç ”ç©¶ä¼šã«ãŠã‘ã‚‹å£é ­ç™ºè¡¨ [æŸ»èª­ã‚ã‚Š]**

1.	**â—‹é›£æ³¢é‡Œå­**ã€ææ™¨ã€å¤§è°·å‰‡å­ã€å±±è¥¿èŠ³è£•.  
ã€Œæ·±å±¤å­¦ç¿’ã«ã‚ˆã‚‹éºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„åˆ†å­ã®äºˆæ¸¬ã¨å¸Œå°‘ç–¾æ‚£ã¸ã®å¿œç”¨,  
ã€æ—¥æœ¬è–¬å­¦ä¼šç¬¬145å›ã€ä¸€èˆ¬å£é ­ç™ºè¡¨, ç¦å²¡, 2025å¹´3æœˆ28æ—¥ï¼ˆ2025.3.26~2025.3.29ï¼‰.

2.	å‰æœ¬ä¿®äººã€äº€æ·µç”±ä¹ƒã€**â—‹é›£æ³¢é‡Œå­**ã€å±±è¥¿èŠ³è£•ã€å¤å±‹èŒ‚æ¨¹ã€æ¿±é‡æ¡ƒå­.  
ã€ŒIn silicoã«ã‚ˆã‚‹ä»£è¬ç•°å¸¸æ€§çµ±åˆå¤±èª¿ç—‡ã®æ–°è¦æ²»ç™‚æ¨™çš„ã¨æ²»ç™‚è–¬å€™è£œã®äºˆæ¸¬ã€  
ä¸€èˆ¬å£é ­ç™ºè¡¨,ã€æ—¥æœ¬è–¬å­¦ä¼šç¬¬145å›ã€ä¸€èˆ¬å£é ­ç™ºè¡¨, ç¦å²¡, 2025å¹´3æœˆ28æ—¥ï¼ˆ2025.3.26~2025.3.29ï¼‰.

3.	**â—‹é›£æ³¢é‡Œå­**ã€ææ™¨ã€å¤§è°·å‰‡å­ã€å±±è¥¿èŠ³è£•.  
ã€Œéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸåŠæ•™å¸«ã‚ã‚Šæ·±å±¤å­¦ç¿’ã«ã‚ˆã‚‹æ²»ç™‚æ¨™çš„åˆ†å­ã®äºˆæ¸¬ã¨å¸Œå°‘ç–¾æ‚£ã¸ã®å¿œç”¨ã€,  
ã€ç¬¬130å› æ—¥æœ¬è§£å‰–å­¦ä¼šï¼ç¬¬102å› æ—¥æœ¬ç”Ÿç†å­¦ä¼šï¼ç¬¬98å› æ—¥æœ¬è–¬ç†å­¦ä¼šåˆåŒå¤§ä¼šã€  
ä¸€èˆ¬å£é ­ç™ºè¡¨, åƒè‘‰, 2025å¹´3æœˆ18æ—¥ï¼ˆ2025.3.17~2025.3.19ï¼‰.

4.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Otani, and Yoshihiro Yamanishi.  
â€œTherapeutic target prediction for rare diseases integrating GWAS and TWAS dataâ€.  
ã€ç¬¬12å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€ä¸€èˆ¬å£é ­ç™ºè¡¨, åƒè‘‰, 2023å¹´9æœˆ7-9æ—¥ (2023.9.7~2023.9.9).ï¼ˆæ¡æŠç‡16/142ï¼‰ 

5.	Midori Iida, ..., **â—‹Satoko Namba**, et al.   
â€œDeveloping a network-based combination therapy approach for complex diseasesâ€.  
ã€CBIå­¦ä¼š2022å¹´å¤§ä¼šã€,ä¸€èˆ¬å£é ­ç™ºè¡¨, æ±äº¬, 2022å¹´10æœˆ25æ—¥ (2022.10.25~2022.10.27).  

6.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ï¼šéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸæ²»ç™‚æ¨™çš„äºˆæ¸¬ã€,  
ã€ç¬¬11å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€ãƒã‚¤ãƒ©ã‚¤ãƒˆãƒˆãƒ©ãƒƒã‚¯, å¤§é˜ª, 2022å¹´9æœˆ14æ—¥ (2022.9.13~2022.9.15).  

7.	**â—‹Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
â€œFrom drug repositioning to target repositioning: omics-based prediction of therapeutic targets for a variety of diseasesâ€.  
ã€CBIå­¦ä¼š2021å¹´å¤§ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2021å¹´10æœˆ27æ—¥ (2021.10.26~2021.10.28).

---

### ğŸ¯**å›½å†…å­¦ä¼šãƒ»ç ”ç©¶ä¼šã«ãŠã‘ã‚‹å£é ­ç™ºè¡¨ [æŸ»èª­ãªã—]**

1.	**â—‹é›£æ³¢é‡Œå­**, ææ™¨, å¤§è°·å‰‡å­, å±±è¥¿èŠ³è£•.  
ã€Œæ©Ÿæ¢°å­¦ç¿’ã«ã‚ˆã‚‹æ²»ç™‚æ¨™çš„åˆ†å­ã®äºˆæ¸¬ã¨å¸Œå°‘ç–¾æ‚£ã¸ã®å¿œç”¨ã€,  
ã€ç¬¬10å›CBIå­¦ä¼š å€‹åˆ¥åŒ–åŒ»ç™‚ç ”ç©¶ä¼šã€, å²é˜œ, 2024å¹´2æœˆ27æ—¥.  

2.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ï¼šéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸæ²»ç™‚æ¨™çš„äºˆæ¸¬ã€,  
ã€ç”Ÿå‘½æƒ…å ±ç§‘å­¦è‹¥æ‰‹ã®ä¼šã®ç¬¬14å›ç ”ç©¶ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2022å¹´9æœˆ10-11æ—¥.  

3.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€Œéºä¼å­ç™ºç¾ãƒ‡ãƒ¼ã‚¿ã‚’ç”¨ã„ãŸã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ã®ææ¡ˆã€,  
ã€ç”Ÿå‘½æƒ…å ±ç§‘å­¦è‹¥æ‰‹ã®ä¼šã®ç¬¬13å›ç ”ç©¶ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2021å¹´10æœˆ22-24æ—¥.

4.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, é£¯ç”°ç·‘, å±±è¥¿èŠ³è£•.  
ã€Œæ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„åˆ†å­ã¨æ²»ç™‚è–¬ã®æ¢ç´¢ã€,  
ã€ç”Ÿå‘½æƒ…å ±ç§‘å­¦è‹¥æ‰‹ã®ä¼šã®ç¬¬12å›ç ”ç©¶ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2020å¹´8æœˆ27-28æ—¥.

5.	**â—‹é›£æ³¢é‡Œå­**, ä¹…ä¿ç”°æµ©è¡Œ.  
ã€Œç³–å°¿ç—…ãƒ©ãƒƒãƒˆã¨å¥å¸¸ãƒ©ãƒƒãƒˆã«ãŠã‘ã‚‹è¡€ä¸­ã‚¤ãƒ³ã‚¹ãƒªãƒ³æ¿ƒåº¦å¤‰åŒ–ã®æ¯”è¼ƒã€,  
ã€ç¬¬äºŒå›æ•°ç†ç”Ÿç‰©å­¦å¤ã®å­¦æ ¡2019ã€, ç¥å¥ˆå·, 2019å¹´8æœˆ29-31æ—¥.

7.	**â—‹é›£æ³¢é‡Œå­**, ä¹…ä¿ç”°æµ©è¡Œ.  
ã€Œç³–å°¿ç—…ãƒ©ãƒƒãƒˆã¨å¥å¸¸ãƒ©ãƒƒãƒˆã«ãŠã‘ã‚‹è¡€ä¸­ã‚¤ãƒ³ã‚¹ãƒªãƒ³æ¿ƒåº¦å¤‰åŒ–ã®æ¯”è¼ƒã€,  
ã€è±Šç”°ç†åŒ–å­¦ç ”ç©¶æ‰€ç‰¹å®šèª²é¡Œã€€å¤åˆå®¿ã€, æ²–ç¸„, 2019å¹´8æœˆ17-19æ—¥.

---

### ğŸ¯**å›½å†…å­¦ä¼šãƒ»ç ”ç©¶ä¼šç­‰ã«ãŠã‘ã‚‹ãƒã‚¹ã‚¿ãƒ¼ç™ºè¡¨**

1.	é˜ªå£åŒè‘‰ã€ç”°ä¸­æœªæ¥ã€**â—‹é›£æ³¢é‡Œå­**ã€ä¸Šæ¢é™½å¹³ã€åº„å¸ç«œéº»ã€èŠæ± ç´€åºƒã€å±±è¥¿èŠ³è£•.  
ã€ŒæŠ—è€åŒ–åŠ¹æœã‚’æŒã¤åŒ–åˆç‰©ã®åŒ–å­¦çš„ç‰¹å¾´ã‚„ä½œç”¨æ©Ÿåºã®æƒ…å ±è§£æã€,  
ã€æ—¥æœ¬è–¬å­¦ä¼šç¬¬145å›ã€ä¸€èˆ¬ãƒã‚¹ã‚¿ãƒ¼ç™ºè¡¨, ç¦å²¡, 2025å¹´3æœˆ27æ—¥ï¼ˆ2025.3.26~2025.3.29ï¼‰.

2.	é˜ªå£åŒè‘‰ã€ç”°ä¸­æœªæ¥ã€**â—‹é›£æ³¢é‡Œå­**ã€ä¸Šæ¢é™½å¹³ã€åº„å¸ç«œéº»ã€èŠæ± ç´€åºƒã€å±±è¥¿èŠ³è£•.  
ã€ŒæŠ—è€åŒ–ãƒªãƒ—ãƒ­ã‚°ãƒ©ãƒŸãƒ³ã‚°ã‚’èª˜å°ã™ã‚‹ä½åˆ†å­åŒ–åˆç‰©ã®è§£æã¨äºˆæ¸¬ã€,  
ã€ç¬¬130å› æ—¥æœ¬è§£å‰–å­¦ä¼šï¼ç¬¬102å› æ—¥æœ¬ç”Ÿç†å­¦ä¼šï¼ç¬¬98å› æ—¥æœ¬è–¬ç†å­¦ä¼šåˆåŒå¤§ä¼šã€  
ä¸€èˆ¬ãƒã‚¹ã‚¿ãƒ¼ç™ºè¡¨, åƒè‘‰, 2025å¹´3æœˆ18æ—¥ï¼ˆ2025.3.17~2025.3.19ï¼‰.

3.	å‰æœ¬ä¿®äºº, äº€æ·µç”±ä¹ƒ, **â—‹é›£æ³¢é‡Œå­**, å±±è¥¿èŠ³è£•, å¤å±‹èŒ‚æ¨¹, æ¿±é‡æ¡ƒå­.  
ã€Œçµ±åˆå¤±èª¿ç—‡æ§˜ãƒ¢ãƒ‡ãƒ«ãƒã‚¦ã‚¹ã«å¯¾ã™ã‚‹æ–°è¦æ²»ç™‚æ¨™çš„ã¨æ–°è–¬ã®äºˆæ¸¬ã€,  
ã€ç¬¬61å›åŒ–å­¦é–¢é€£æ”¯éƒ¨åˆåŒä¹å·å¤§ä¼šã€, ç¦å²¡, 2024å¹´6æœˆ29æ—¥.

4.	äº€æ·µç”±ä¹ƒ, **â—‹é›£æ³¢é‡Œå­**, é–¢è°· æ‹“æµ·, å¤§è°· å‰‡å­, å²©ç”° é€šå¤«, å±±è¥¿ èŠ³è£•.  
ã€Œæ©Ÿæ¢°å­¦ç¿’ã«ã‚ˆã‚‹è–¬å‰¤æ¨™çš„åˆ†å­äºˆæ¸¬ã¨è–¬å‰¤çµ„ã¿åˆã‚ã›åŠ¹æœã®æ¤œè¨ã€,  
ã€æ—¥æœ¬è–¬å­¦ä¼šç¬¬144å¹´ä¼šã€, ç¥å¥ˆå·, 2024å¹´3æœˆ30 (2024.3.28~2024.3.31).

5.	äº€æ·µç”±ä¹ƒ, **â—‹é›£æ³¢é‡Œå­**, é–¢è°· æ‹“æµ·, å¤§è°· å‰‡å­, å²©ç”° é€šå¤«, å±±è¥¿ èŠ³è£•.  
ã€Œã‚·ãƒŠã‚¸ãƒ¼åŠ¹æœã‚’é«˜ã‚ã‚‹è–¬ç‰©ã®çµ„ã¿åˆã‚ã›ã‚’äºˆæ¸¬ã™ã‚‹æƒ…å ±æŠ€è¡“ã®é–‹ç™ºã€,  
ã€ç¬¬97å›æ—¥æœ¬è–¬ç†å­¦ä¼šå¹´ä¼šã€, ç¥å¥ˆå·, 2023å¹´12æœˆ15ï¼ˆ2023.12.14~2023.12.16ï¼‰.

6.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Otani, and Yoshihiro Yamanishi.  
â€œTherapeutic target prediction for rare diseases integrating GWAS and TWAS dataâ€.  
ã€ç¬¬12å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€ãƒã‚¹ã‚¿ãƒ¼ç™ºè¡¨, åƒè‘‰, 2023å¹´9æœˆ7æ—¥ (2023.9.7~2023.9.9).

7.	**â—‹Satoko Namba**, Michio Iwata and Yoshihiro Yamanishi.  
ã€Œã‚¿ãƒ¼ã‚²ãƒƒãƒˆãƒªãƒã‚¸ã‚·ãƒ§ãƒ‹ãƒ³ã‚°ï¼šéºä¼å­æ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„äºˆæ¸¬ã€,  
ã€ç¬¬10å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2021å¹´9æœˆ27æ—¥ (2021.9.27ã€œ2021.9.29).

8.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, é£¯ç”°ç·‘, å±±è¥¿èŠ³è£•.  
ã€Œæ‘‚å‹•å¿œç­”ãƒˆãƒ©ãƒ³ã‚¹ã‚¯ãƒªãƒ—ãƒˆãƒ¼ãƒ ã‚’ç”¨ã„ãŸå‰µè–¬æ¨™çš„åˆ†å­ã¨æ²»ç™‚è–¬ã®æ¢ç´¢ã€,  
ã€ç¬¬9å›ç”Ÿå‘½åŒ»è–¬æƒ…å ±å­¦é€£åˆå¤§ä¼šã€, ã‚ªãƒ³ãƒ©ã‚¤ãƒ³, 2020å¹´9æœˆ1-3æ—¥.

9.	**â—‹Satoko Namba**, Katsuya Ogata, and Shozo Tobimatsu.  
"Frequency dependent effect of iTBS-tACS. English Poster Presentation of Kyushu University School of Medicine"",  
ç¦å²¡, 2018å¹´11æœˆ24æ—¥.

---

### ğŸ“°**ãƒ¡ãƒ‡ã‚£ã‚¢å ±é“**

1. **â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyam Otani, and Yoshihiro Yamanishi.  
ã€Œå¸Œå°‘ç–¾æ‚£ã®å‰µè–¬æ¨™çš„åˆ†å­ã‚’äºˆæ¸¬ã™ã‚‹AIã‚’é–‹ç™ºã€,  
é›£ç—…ãƒ»å¸Œå°‘ç–¾æ‚£ æƒ…å ±ã‚µã‚¤ãƒˆ RareS.(ãƒ¬ã‚¢ã‚º; é›£ç—…ãƒ»å¸Œå°‘ç–¾æ‚£é ˜åŸŸã«ç‰¹åŒ–ã—ãŸä¿¡é ¼æ€§ã®é«˜ã„åŒ»ç™‚æƒ…å ±ã‚µã‚¤ãƒˆ),  
2025å¹´5æœˆ15æ—¥.  
[web page](https://raresnet.com/250515-01/)

2.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyam Otani, and Yoshihiro Yamanishi.  
ã€Œå¸Œå°‘ç–¾æ‚£ã®å‰µè–¬æ¨™çš„åˆ†å­ã‚’äºˆæ¸¬ã§ãã‚‹AIã‚’é–‹ç™º ï½ã‚²ãƒãƒ ã¨éºä¼å­ç™ºç¾ã‚’èåˆã—ã€é›£æ²»æ€§ç–¾æ‚£ã®æ²»ç™‚æ³•ã®é–‹æ‹“ã¸ï½ã€,  
åå¤å±‹å¤§å­¦ ç ”ç©¶æˆæœç™ºä¿¡ã‚µã‚¤ãƒˆ ãƒ—ãƒ¬ã‚¹ãƒªãƒªãƒ¼ã‚¹, 2024å¹´4æœˆ21æ—¥.  
[web page](https://www.nagoya-u.ac.jp/researchinfo/result/2025/04/ai-103.html)

3.	**â—‹Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyam Otani, and Yoshihiro Yamanishi.  
ã€Œå¸Œå°‘ç–¾æ‚£ã®å‰µè–¬æ¨™çš„åˆ†å­ã‚’äºˆæ¸¬ã§ãã‚‹AIã‚’é–‹ç™º ï½ã‚²ãƒãƒ ã¨éºä¼å­ç™ºç¾ã‚’èåˆã—ã€é›£æ²»æ€§ç–¾æ‚£ã®æ²»ç™‚æ³•ã®é–‹æ‹“ã¸ï½ã€,  
æ—¥æœ¬ã®ç ”ç©¶.com, 2024å¹´4æœˆ21æ—¥.  
[web page](https://research-er.jp/articles/view/143717)

4.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•. ã€Œå›½éš›ä¼šè­°å‚åŠ å ±å‘Š ISMB2022ã€,  
æ—¥æœ¬ãƒã‚¤ã‚ªã‚¤ãƒ³ãƒ•ã‚©ãƒãƒ†ã‚£ã‚¯ã‚¹å­¦ä¼šãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ¬ã‚¿ãƒ¼ç¬¬42å·, 2023å¹´1æœˆ31æ—¥.  
[web page](https://www.jsbi.org/media/files/_u/topic/file/nl42.pdf)

5. **â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€ŒåŒ»è–¬å“é–‹ç™ºã«é‡è¦ãªæ²»ç™‚æ¨™çš„åˆ†å­ã€ãƒ“ãƒƒã‚°ãƒ‡ãƒ¼ã‚¿ã‹ã‚‰é«˜ç²¾åº¦äºˆæ¸¬ã™ã‚‹æ‰‹æ³•ã‚’é–‹ç™ºï¼ä¹å·¥å¤§ã€,  
åŒ»ç™‚å¾“äº‹è€…ã®ç‚ºã®æœ€æ–°åŒ»ç™‚ãƒ‹ãƒ¥ãƒ¼ã‚¹ã‚„æ§˜ã€…ãªæƒ…å ±ãƒ»ãƒ„ãƒ¼ãƒ«ã‚’æä¾›ã™ã‚‹åŒ»ç™‚ç·åˆã‚µã‚¤ãƒˆ QLifePro,  
2022å¹´7æœˆ6æ—¥.  
[web page](https://www.qlifepro.com/news/20220706/target-repositioning.html)

6.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€Œç”Ÿä½“åˆ†å­ã¨ç–¾æ‚£ã®ãƒ“ãƒƒã‚°ãƒ‡ãƒ¼ã‚¿ã‹ã‚‰æ²»ç™‚æ¨™çš„åˆ†å­ã‚’é«˜ç²¾åº¦ã§äºˆæ¸¬ã™ã‚‹AIã‚’é–‹ç™ºã€,  
æ—¥æœ¬æœ€å¤§ã®åŒ–å­¦ãƒãƒ¼ã‚¿ãƒ«ã‚µã‚¤ãƒˆChem-Station ã‚¹ãƒãƒƒãƒˆãƒ©ã‚¤ãƒˆãƒªã‚µãƒ¼ãƒç¬¬408å› å¯„ç¨¿, 2022å¹´8æœˆ16æ—¥.  
[web page](https://www.chem-station.com/blog/2022/08/drtr.html#google_vignette)  

7.	**â—‹é›£æ³¢é‡Œå­**, å²©ç”°é€šå¤«, å±±è¥¿èŠ³è£•.  
ã€Œç”Ÿä½“åˆ†å­ã¨ç–¾æ‚£ã®ãƒ“ãƒƒã‚°ãƒ‡ãƒ¼ã‚¿ã‹ã‚‰æ²»ç™‚æ¨™çš„åˆ†å­ã‚’é«˜ç²¾åº¦ã§äºˆæ¸¬ã™ã‚‹AIã‚’é–‹ç™ºã€,  
ä¹å·å·¥æ¥­å¤§å­¦ãƒ—ãƒ¬ã‚¹ãƒªãƒªãƒ¼ã‚¹, 2022å¹´7æœˆ4æ—¥.  
[web page](https://www.kyutech.ac.jp/whats-new/press/entry-9220.html)

---

<a href="/en/achievements.html">[English Version]</a>
